Complement Inhibitor [EPC] - N0000175575

Pharmacologic Code	N0000175575
Pharmacologic Name	Complement Inhibitor
Pharmacologic Uses	complement inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 11 products whose active ingredient are classified under the same pharmacologic class Complement Inhibitor [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	25682-001	Soliris	Non-Proprietary Name: Eculizumab	Injection, Solution, Concentrate	Intravenous	Alexion Pharmaceuticals Inc.	ACTIVE
	25682-022	Ultomiris	Non-Proprietary Name: Ravulizumab	Solution, Concentrate	Intravenous	Alexion Pharmaceuticals Inc.	ACTIVE
	25682-025	Ultomiris	Non-Proprietary Name: Ravulizumab	Solution, Concentrate	Intravenous	Alexion Pharmaceuticals Inc.	ACTIVE
	25682-028	Ultomiris	Non-Proprietary Name: Ravulizumab	Solution, Concentrate	Intravenous	Alexion Pharmaceuticals Inc.	ACTIVE
	50474-990	Zilbrysq	Non-Proprietary Name: Zilucoplan	Injection, Solution	Subcutaneous	Ucb, Inc.	ACTIVE
	50474-991	Zilbrysq	Non-Proprietary Name: Zilucoplan	Injection, Solution	Subcutaneous	Ucb, Inc.	ACTIVE
	50474-992	Zilbrysq	Non-Proprietary Name: Zilucoplan	Injection, Solution	Subcutaneous	Ucb, Inc.	ACTIVE
	61755-014	Veopoz	Non-Proprietary Name: Pozelimab	Injection, Solution	Intravenous; Subcutaneous	Regeneron Pharmaceuticals, Inc.	ACTIVE
	73606-010	Empaveli	Non-Proprietary Name: Pegcetacoplan	Injection, Solution	Subcutaneous	Apellis Pharmaceuticals, Inc.	ACTIVE
	73606-020	Syfovre	Non-Proprietary Name: Pegcetacoplan	Injection, Solution	Intravitreal	Apellis Pharmaceuticals, Inc.	ACTIVE
	82829-002	Izervay	Non-Proprietary Name: Avacincaptad Pegol	Injection	Intravitreal	Astellas Pharma Us, Inc.	ACTIVE